Biovie (BIVI) Accumulated Expenses (2013 - 2018)
Biovie (BIVI) posted Accumulated Expenses of $354167.0 for Q2 2018, up 13.33% sequentially from $312500.0 in Q1 2018, and up 183.33% YoY from $125000.0 in Q2 2017.
Biovie (BIVI) Accumulated Expenses (2013 - 2018) Analysis & Trends
Biovie has reported Accumulated Expenses for 6 years, with the latest figure at $354167.0 in Q2 2018.
- Quarterly Accumulated Expenses rose 183.33% year-over-year to $354167.0 in Q2 2018, while the trailing twelve-month figure through Jun 2018 was $354167.0 (up 183.33% YoY) and the FY2018 annual result came in at $354167.0, up 183.33% from the prior year.
- Accumulated Expenses grew to $354167.0 in Q2 2018 per BIVI's latest filing, from $312500.0 in the prior quarter.
- Over five years, Accumulated Expenses peaked at $624612.0 in Q4 2016 and troughed at $62500.0 in Q1 2017.
- A 5-year average of $325789.2 and a median of $317725.0 in 2015 frame the typical range for Accumulated Expenses.
- The sharpest annual moves came in 2014 and 2017: Accumulated Expenses soared 1346.04% in 2014, then slumped 85.93% in 2017.
- Over 5 years, Accumulated Expenses stood at $242212.0 in 2014, then soared by 66.67% to $403688.0 in 2015, then jumped by 54.73% to $624612.0 in 2016, then slumped by 59.98% to $250000.0 in 2017, then jumped by 41.67% to $354167.0 in 2018.
- According to Business Quant data, Accumulated Expenses over the past three periods registered $354167.0, $312500.0, and $250000.0 for Q2 2018, Q1 2018, and Q4 2017 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Biovie | 14.17 Mn | 14.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | 354,167.00 |
| Mar 31, 2018 | 312,500.00 |
| Dec 31, 2017 | 250,000.00 |
| Jun 30, 2017 | 125,000.00 |
| Mar 31, 2017 | 62,500.00 |
| Dec 31, 2016 | 624,612.00 |
| Sep 30, 2016 | 562,112.00 |
| Jun 30, 2016 | 499,612.00 |
| Mar 31, 2016 | 444,056.00 |
| Dec 31, 2015 | 403,688.00 |
| Sep 30, 2015 | 363,319.00 |
| Jun 30, 2015 | 322,950.00 |
| Mar 31, 2015 | 282,581.00 |
| Dec 31, 2014 | 242,212.00 |
| Sep 30, 2014 | 201,844.00 |
| Jun 30, 2014 | 161,475.00 |
| Dec 31, 2013 | 16,750.00 |